rxstat › Drug prices › Rosiglitazone

Rosiglitazone (Avandia) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Rosiglitazone 2 mg tablet costs about $1.03 to $1.50 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Rosiglitazone has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKONNSNL
2 mg Tabletper tablet$1.03$1.03$1.22–$1.50
4 mg Tabletper tablet$1.62$1.62$1.92–$2.35
8 mg Tabletper tablet$2.31$2.31$2.75–$3.36
Plan coverageCoveredSpecial approvalCoveredNot coveredPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 3 products
  • Rosiglitazone 2 mg Tablet · AAP
    DIN 02403366 · $1.03/tablet · Covered
  • Rosiglitazone 4 mg Tablet · AAP
    DIN 02403374 · $1.62/tablet · Covered
  • Rosiglitazone 8 mg Tablet · AAP
    DIN 02403382 · $2.31/tablet · Covered
Saskatchewan: 3 products
  • Rosiglitazone 2 mg Tablet · AAP
    DIN 02403366 · $1.03/tablet · Special approval
  • Rosiglitazone 4 mg Tablet · AAP
    DIN 02403374 · $1.62/tablet · Special approval
  • Rosiglitazone 8 mg Tablet · AAP
    DIN 02403382 · $2.31/tablet · Special approval
Ontario: 6 products
  • Rosiglitazone 2 mg Tablet · A A Pharma Inc.
    DIN 02403366 · $1.22/tablet · Covered
  • Rosiglitazone 4 mg Tablet · A A Pharma Inc.
    DIN 02403374 · $1.92/tablet · Covered
  • Rosiglitazone 8 mg Tablet · A A Pharma Inc.
    DIN 02403382 · $2.75/tablet · Covered
  • Avandia 2 mg Tablet · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02241112 · no listed price · Not covered
  • Avandia 4 mg Tablet · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02241113 · no listed price · Not covered
  • Avandia 8 mg Tablet · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02241114 · no listed price · Not covered
Nova Scotia: 6 products
  • Avandia 2 mg Tablet · GSK
    DIN 02241112 · no listed price · Not covered
  • Rosiglitazone 2 mg Tablet · AAP
    DIN 02403366 · no listed price · Not covered
  • Avandia 4 mg Tablet · GSK
    DIN 02241113 · no listed price · Not covered
  • Rosiglitazone 4 mg Tablet · AAP
    DIN 02403374 · no listed price · Not covered
  • Avandia 8 mg Tablet · GSK
    DIN 02241114 · no listed price · Not covered
  • Rosiglitazone 8 mg Tablet · AAP
    DIN 02403382 · no listed price · Not covered
Newfoundland and Labrador: 6 products
  • Rosiglitazone 2 mg Tablet · AAP
    DIN 02403366 · $1.50/tablet · Price list
  • Avandia 2 mg Tablet · GSK
    DIN 02241112 · $1.65/tablet · Price list
  • Rosiglitazone 4 mg Tablet · AAP
    DIN 02403374 · $2.35/tablet · Price list
  • Avandia 4 mg Tablet · GSK
    DIN 02241113 · $2.59/tablet · Price list
  • Rosiglitazone 8 mg Tablet · AAP
    DIN 02403382 · $3.36/tablet · Price list
  • Avandia 8 mg Tablet · GSK
    DIN 02241114 · $3.68/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 5
Reports on file
8

Reports by product

The DIN is printed on your prescription label.

Resolved
ROSIGLITAZONE
2MG · TABLET · AA PHARMA INC
DIN 02403366 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
Discontinued
AVANDIA
4MG · TABLET · GLAXOSMITHKLINE INC
DIN 02241113
Discontinued
AVANDIA
2MG · TABLET · GLAXOSMITHKLINE INC
DIN 02241112
Discontinued
AVANDIA
8MG · TABLET · GLAXOSMITHKLINE INC
DIN 02241114
Resolved
AVANDIA
8MG · TABLET · GLAXOSMITHKLINE INC
DIN 02241114 · ended Apr 22, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-ROSIGLITAZONE
4MG · TABLET · APOTEX INC
DIN 02403374 · ended Oct 13, 2017 · Disruption of the manufacture of the drug.
Resolved
APO-ROSIGLITAZONE
2MG · TABLET · APOTEX INC
DIN 02403366 · ended Oct 13, 2017 · Disruption of the manufacture of the drug.
Resolved
AVANDIA
2MG · TABLET · GLAXOSMITHKLINE INC
DIN 02241112 · ended Jun 13, 2017 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Rosiglitazone. Health Canada has 8 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Rosiglitazone is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BG).

Recent changes

Common questions

How much does Rosiglitazone cost in Canada?

Rosiglitazone 2 mg tablet costs about $1.03 to $1.50 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Is Rosiglitazone covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; Nova Scotia: not covered; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Rosiglitazone be back in stock in Canada?

Rosiglitazone has no active shortage; supply is normal per Health Canada reports.

Why is Rosiglitazone in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (blood glucose lowering drugs, excl. insulins)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.